Autoimmune skin and connective tissue diseases and risk of venous thromboembolism

A population-based case-control study

S. A. Johannesdottir, M. Schmidt, E. Puhó, H. T. Sørensen

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14721 VTE cases and 147210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not.

Original languageEnglish
Pages (from-to)815-821
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume10
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Skin and Connective Tissue Diseases
Venous Thromboembolism
Case-Control Studies
Connective Tissue Diseases
Population
Confidence Intervals
Autoimmune Diseases
Skin Diseases
Incidence
Odds Ratio
Population Control
Juvenile Arthritis
Fibrinolysis
Denmark
Systemic Lupus Erythematosus
Anticoagulants
Up-Regulation
Down-Regulation
Logistic Models
Parturition

Keywords

  • Autoimmune diseases
  • Case-control study
  • Connective tissue diseases
  • Epidemiology
  • Skin diseases
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Cite this

Autoimmune skin and connective tissue diseases and risk of venous thromboembolism : A population-based case-control study. / Johannesdottir, S. A.; Schmidt, M.; Puhó, E.; Sørensen, H. T.

In: Journal of Thrombosis and Haemostasis, Vol. 10, No. 5, 05.2012, p. 815-821.

Research output: Contribution to journalArticle

@article{60f5d0f600dc47ad9ae27df2f4efc620,
title = "Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: A population-based case-control study",
abstract = "Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14721 VTE cases and 147210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95{\%} confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95{\%} CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95{\%} CI 1.5-3.7) and 91-365 days (IRR 2.0; 95{\%} CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95{\%} CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95{\%} CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95{\%} CI 1.7-4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not.",
keywords = "Autoimmune diseases, Case-control study, Connective tissue diseases, Epidemiology, Skin diseases, Venous thromboembolism",
author = "Johannesdottir, {S. A.} and M. Schmidt and E. Puh{\'o} and S{\o}rensen, {H. T.}",
year = "2012",
month = "5",
doi = "10.1111/j.1538-7836.2012.04666.x",
language = "English",
volume = "10",
pages = "815--821",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Autoimmune skin and connective tissue diseases and risk of venous thromboembolism

T2 - A population-based case-control study

AU - Johannesdottir, S. A.

AU - Schmidt, M.

AU - Puhó, E.

AU - Sørensen, H. T.

PY - 2012/5

Y1 - 2012/5

N2 - Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14721 VTE cases and 147210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not.

AB - Background: Systemic inflammation is associated with vessel wall damage, upregulation of procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis. Autoimmune diseases may therefore increase the risk of venous thromboembolism (VTE). Objectives: To examine whether autoimmune skin and connective tissue diseases are associated with increased VTE risk. Methods: We conducted this population-based case-control study in northern Denmark, using administrative databases. From 1999 to 2009, we identified 14721 VTE cases and 147210 birth year-matched, sex-matched and county-matched population controls. The date of diagnosis/matching was considered to be the index date for cases and controls. For all study subjects, we identified hospital diagnoses of autoimmune skin or connective tissue diseases between 1977 and the index date. We used conditional logistic regression with adjustment for VTE risk factors to calculate odds ratios and 95% confidence intervals (CIs) for patients with vs. without autoimmune disease. Given the risk-set sampling design, odds ratios estimate incidence rate ratios (IRRs). Results: Autoimmune skin disease was not associated with VTE (IRR 1.0; 95% CI 0.9-1.2). Patients with connective tissue disease had an increased VTE risk within 90 days (IRR 2.3; 95% CI 1.5-3.7) and 91-365 days (IRR 2.0; 95% CI 1.5-2.8) after diagnosis, but not thereafter (IRR 1.1; 95% CI 1.0-1.2). Among connective tissue diseases, the greatest overall risk increases were found for juvenile rheumatoid arthritis (IRR 3.0; 95% CI 1.4-6.4) and systemic lupus erythematosus (IRR 2.8; 95% CI 1.7-4.7). Conclusions: Autoimmune connective tissue disease was associated with an increased risk of VTE within 1 year after diagnosis, whereas skin diseases were not.

KW - Autoimmune diseases

KW - Case-control study

KW - Connective tissue diseases

KW - Epidemiology

KW - Skin diseases

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84860445149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860445149&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2012.04666.x

DO - 10.1111/j.1538-7836.2012.04666.x

M3 - Article

VL - 10

SP - 815

EP - 821

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 5

ER -